Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
IHE
56
HOLDINGS
33%
ALSO IN FTXH
FTXH
51
HOLDINGS
31%
ALSO IN IHE
SECTOR DRIFT (IHE minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 25.4% | 8.2% | 8.2% |
|
MERCK & CO. INC. | 5.1% | 8.3% | 5.1% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% | 7.6% | 5.0% |
|
PFIZER INC | 4.5% | 6.5% | 4.5% |
|
ELI LILLY & CO | 21.5% | 4.1% | 4.1% |
IHE Overweight Relative to FTXH
|
ELI LILLY & CO | 17.4% |
|
JOHNSON & JOHNSON | 17.1% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% |
|
ZOETIS INC | 2.0% |
|
ELANCO ANIMAL HEALTH, INC. | 2.0% |
|
AXSOME THERAPEUTICS, INC. | 1.8% |
|
TERNS PHARMACEUTICALS, INC. | 1.1% |
|
CRINETICS PHARMACEUTICALS INC | 1.0% |
|
TARSUS PHARMACEUTICALS, INC. | 0.7% |
|
LIQUIDIA TECHNOLOGIES, INC. | 0.7% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -6.3% |
|
CARDINAL HEALTH INC | -4.4% |
|
BIOGEN IDEC INC | -4.1% |
|
REGENERON PHARMACEUTICALS | -3.9% |
|
GILEAD SCIENCES INC | -3.9% |
|
AMGEN INC | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
VERTEX PHARMACEUTICALS INC | -3.6% |
|
MERCK & CO. INC. | -3.2% |
|
BRISTOL-MYERS SQUIBB CO | -2.6% |